Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$919K Sell
11,853
-310
-3% -$24K ﹤0.01% 3673
2014
Q2
$838K Sell
12,163
-4,010
-25% -$291K ﹤0.01% 3722
2014
Q1
$1.26M Sell
16,173
-1,766
-10% -$127K ﹤0.01% 3257
2013
Q4
$1.29M Buy
17,939
+9,911
+123% +$706K ﹤0.01% 3258
2013
Q3
$610K Sell
8,028
-7,587
-49% -$555K ﹤0.01% 3911
2013
Q2
$1.16M Buy
+15,615
New +$1.05M ﹤0.01% 3165

Other funds holding CRI

UBS's CRI Position: Q3 2014 in Review

UBS reduced its Carter's (CRI) stake by 2.5% in Q3 2014, selling an estimated $24K and leaving 11,853 shares worth $919K. The position accounts for ﹤0.01% of the portfolio, ranked #3673.

UBS first reported a position in CRI in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.29M in Q4 2013. 229 funds tracked by Wall St. Rank hold CRI as of Q3 2014.

  • UBS held 11,853 shares of Carter's worth $919K as of Q3 2014.
  • UBS sold 310 Carter's shares in Q3 2014, an estimated $24K.
  • Carter's made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3673 holding.
  • UBS first reported a position in Carter's in Q2 2013 and has held it in 6 quarters since.
  • UBS's Carter's position peaked at $1.29M in Q4 2013.
  • 229 funds tracked by Wall St. Rank held Carter's as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.